Manufacturer record
Asterisk Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Asterisk Healthcare were declared Not of Standard Quality between December 2024 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AGC240287, Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP (exp Dec 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to IP and Manufacturer's Specification with repect to the test of Dissolution of Domperidone. Listed in the April 2026 alert.
Records by type
3 records linked to Asterisk Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP | Batch AGC240287Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to IP and Manufacturer's Specification with repect to the test of Dissolution of Domperidone.Dissolution | CDL, KolkataCDSCO lab | Apr 2026 |
| Pregabalin & Methylcobalamin Capsules IP | Batch PGC2508006CMfg Aug 2025 · Exp Jan 2027 | DissolutionDissolution | SDTL, PunjabState lab | Mar 2026 |
| Tamcof-Ls Syrup | Batch AGL23022 1CMfg Mar 2024 · Exp Feb 2026 | Sample does not conform to Label claim with respect to the content of Ambroxol HydrochlorideLabelling | DTL ChennaiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.